Full-Time

Senior Field Application Specialist

Cell Therapy & Regulatory Markets

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$160k - $200k/yr

Boston, MA, USA

In Person

Category
Biology & Biotech (3)
, ,
Requirements
  • PhD or Master's in Cell Biology, Immunology, or equivalent
  • 8+ years of experience working directly in or supporting GMP/GxP environments within the biopharmaceutical industry
  • Hands-on experience in GMP/ GxP environments, including assay development, validation, or manufacturing support
  • Deep technical knowledge of CAR-T cell manufacturing processes
  • Strong understanding of regulatory expectations in clinical development
  • Proven ability to communicate complex scientific concepts to diverse audiences, including scientists, QA/QC, and regulatory stakeholders
  • Experience in an international business environment
  • Ability to work in a fast-paced environment, manage deliverables and deadlines simultaneously
  • Excellent communication, presentation and organizational skills
  • Ability to adapt scientific communication in the field based on customer needs
  • Excellent knowledge of English both in word and writing
  • Travel frequently in the field to customers (>60%)
Responsibilities
  • Serve as the primary scientific and technical authority for customers across the region, specifically those operating in CAR-T, cell therapy development, and GMP/GxP environments
  • Act as the Subject Matter Expert (SME) for customers in regulated spaces; advise on CST product selection meeting GMP, ISO 13485, and quality standards, including assay validation, comparability studies, and documentation
  • End-to-end workflow support across the entire continuum—from discovery and translational research to clinical manufacturing and Quality Control (QC)
  • Regulatory inquiry management: Resolve complex customer inquiries regarding traceability, reproducibility, lot-to-lot consistency, and change control protocols
  • Risk mitigation: Support technology transfer teams and clinical development groups to ensure seamless integration of CST reagents into validated workflows
  • Partner with the regional commercial team to identify and qualify high-value opportunities within the Cell and Gene Therapy sector
  • Deliver high-impact technical presentations and "sales launch packages" that address the specific pain points of researchers in regulatory markets
  • Revenue accountability: Drive successful product adoption across the region to meet or exceed territory budgetary goals and revenue forecasts
  • KOL network building: Cultivate a high-level network across the region identify and facilitate joint collaborations between key customers and CST R&D
  • Market intelligence: Represent CST at premier scientific conferences and industry meetings to maintain a pulse on regulatory shifts and competitor landscapes
  • Collaboration: Collaborate with Global Marketing, Product Management, and R&D to align customer needs with CST’s product roadmap, influencing the development of next-generation reagents for the clinical market
  • Regional mentorship: Foster a collaborative regional FAS culture; act as a technical escalation point and provide "people cover"/mentorship for the broader FAS team as needed
  • Training & Enablement: Work with the Global Product Trainer to design and deliver specialized workshops for sales representatives and distribution partners
  • Early Access Program (EAP): Lead the technical execution of Early Access Programs in the region, bridging the gap between R&D and field-testing
Desired Qualifications
  • Prior sales experience and commercial mindset with demonstrated business acumen
  • Experience with confocal and fluorescent microscopy
  • Experience analyzing and responding to regional sales and revenue trends
  • Ability to proactively manage multiple priorities and deadlines across time zones
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Cell signaling market grows to $7.11 billion by 2030 at 7.3% CAGR.
  • Bio-Techne adds Simple Western validation to CST antibodies in 2023.
  • CST invests $17.5M in Manchester property in July 2022 for expansion.

What critics are saying

  • Leveragen nanobodies displace CST monoclonal antibodies in 12-24 months.
  • Lunaphore scales single B cell screening, eroding CST revenue in 12-18 months.
  • Visiopharm dependency fails if Indica Labs captures market in 18-36 months.

What makes Cell Signaling Technology unique

  • CST launches SignalStar Multiplex IHC for 8-plex amplification in two days.
  • CST partners with Visiopharm to integrate SignalStar with Phenoplex software.
  • CST expands chimeric monoclonal antibodies to mouse, horse, and feline species.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Cell Signaling Technology who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Company News

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.

AZoNetwork
Sep 14th, 2023
Flexible Spatial Biology Solution for Up to 8-Plex Amplification in Two Days: CST Launches SignalStar™ Multiplex IHC

Cell Signaling Technology (CST) , a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.